Silverarc Capital Management »

Cellectar Biosciences shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $894k 322k 2.78

More positions owned by Silverarc Capital Management

Ascendis Pharma A/s Ord Shs (ASND)
Celcuity (CELC)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Immunome (IMNM)
Dianthus Therapeutics (DNTH)
Rhythm Pharmaceuticals (RYTM)
Oruka Therapeutics (ORKA)
Monte Rosa Therapeutics (GLUE)
Syndax Pharmaceuticals (SNDX)
Enliven Therapeutics (ELVN)
Immunovant (IMVT)
Erasca (ERAS)
Sagimet Biosciences Com Ser A (SGMT)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Silverarc Capital Management

Top funds holding Cellectar Biosciences

Caligan Partners
Stempoint Capital
Vanguard Capital Management
Silverarc Capital Management
Bleichroeder
Jupiter Topco
Balyasny Asset Management
Nantahala Capital Management
Empery Asset Management
Diadema Partners
Stonepine Capital Management
Persistent Asset Partners
Boothbay Fund Management
Geode Capital Management
Vanguard Fiduciary Trust

View all funds holding Cellectar Biosciences